Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Pharmacogenetics Implementation Consortium Gets $5M in NIH Funding

NEW YORK (GenomeWeb) – The National Institutes of Health have awarded researchers at St. Jude Children's Research Hospital and Stanford University $5 million over the next five years for their continued work as part of the Clinical Pharmacogenetics Implementation Consortium.

CPIC develops guidelines on pharmacogenetic variants that healthcare providers can use to guide treatment and dosing decisions. Mary Relling, CPIC co-chair and St. Jude Pharmaceutical Sciences Department chair, said in a statement that the latest funding from the NIH is necessary to further advance pharmacogenetic testing into the clinic.

The funding will help CPIC continue its work creating and updating pharmacogenetics guidelines, adding drug-gene pairings, and creating electronic tables that can facilitate integration within electronic health records. CPIC also works with other stakeholders in the genomics community to coordinate efforts and align guidelines.

For example, CPIC worked with the Dutch Pharmacogenetics Working Group and around 30 experts to try to align genotype-to-phenotype translations for CYP2D6, one of the most widely tested pharmacogenetics genes.

"All of CPIC’s content is freely available on the CPIC website, and this funding will allow us to continue to update and expand this content,” said Teri Klein, CPIC co-chair from Stanford University.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.